• 1. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 4. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
• 5. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes

Recent Advances in the Application of 1-Bromo-4-fluoro-2-methyl-3-nitrobenzene (CAS: 1227210-35-6) in Chemical Biology and Pharmaceutical Research

The compound 1-Bromo-4-fluoro-2-methyl-3-nitrobenzene (CAS: 1227210-35-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile reactivity and potential applications in drug discovery and material science. This research briefing aims to summarize the latest findings and advancements related to this compound, highlighting its synthesis, characterization, and applications in various domains.

Recent studies have demonstrated that 1-Bromo-4-fluoro-2-methyl-3-nitrobenzene serves as a critical intermediate in the synthesis of complex organic molecules, particularly in the development of novel pharmaceuticals. Its unique structural features, including the presence of bromo, fluoro, and nitro functional groups, make it an attractive candidate for cross-coupling reactions and other synthetic transformations. Researchers have successfully employed this compound in the synthesis of bioactive molecules with potential therapeutic applications, such as kinase inhibitors and antimicrobial agents.

One of the most notable advancements involves the use of 1-Bromo-4-fluoro-2-methyl-3-nitrobenzene in the development of targeted cancer therapies. A 2023 study published in the Journal of Medicinal Chemistry reported the synthesis of a series of small-molecule inhibitors using this compound as a key building block. The inhibitors exhibited potent activity against specific oncogenic kinases, demonstrating promising results in preclinical models. The study also highlighted the compound's role in improving the pharmacokinetic properties of the resulting drug candidates.

In addition to its pharmaceutical applications, 1-Bromo-4-fluoro-2-methyl-3-nitrobenzene has been explored in material science. Recent research has shown that this compound can be utilized in the synthesis of advanced organic materials, such as liquid crystals and organic semiconductors. Its electron-withdrawing nitro group and halogen substituents contribute to the tuning of electronic properties, making it valuable for designing materials with specific optoelectronic characteristics.

Despite its promising applications, challenges remain in the large-scale synthesis and purification of 1-Bromo-4-fluoro-2-methyl-3-nitrobenzene. Recent efforts have focused on optimizing synthetic routes to improve yield and reduce environmental impact. For instance, a 2022 study in Organic Process Research & Development described a greener approach using catalytic methods, which minimized waste generation and enhanced efficiency.

In conclusion, 1-Bromo-4-fluoro-2-methyl-3-nitrobenzene (CAS: 1227210-35-6) continues to be a compound of significant interest in chemical biology and pharmaceutical research. Its multifaceted applications, from drug discovery to material science, underscore its importance as a versatile intermediate. Future research is expected to further explore its potential, particularly in the development of next-generation therapeutics and functional materials.

• 1427502-92-8(2-Bromo-3-fluoro-6-nitrotoluene)
• 1820613-94-2(1,3-Dibromo-4-fluoro-2-methyl-5-nitrobenzene)
• 170098-98-3(1-Bromo-4-fluoro-2-methyl-5-nitrobenzene)
• 1804841-59-5(6-Bromo-3-fluoro-2-nitrobenzaldehyde)
• 1352397-24-0(4-Bromo-3-fluoro-2-nitrotoluene)
• 502496-33-5(2-Bromo-4-fluoro-6-nitrotoluene)
• 1224629-03-1(5-Bromo-1-fluoro-3-methyl-2-nitrobenzene)
• 1427502-98-4(6-Amino-4-bromo-3-fluoro-2-nitrotoluene)
• 1427503-16-9(2-Amino-4-bromo-3-fluoro-6-nitrotoluene)
• 64695-96-1(1-Bromo-5-fluoro-2-methyl-4-nitrobenzene)